MXPA03007626A - Heterocarpina, una proteina de union de ghrh humana. - Google Patents

Heterocarpina, una proteina de union de ghrh humana.

Info

Publication number
MXPA03007626A
MXPA03007626A MXPA03007626A MXPA03007626A MXPA03007626A MX PA03007626 A MXPA03007626 A MX PA03007626A MX PA03007626 A MXPA03007626 A MX PA03007626A MX PA03007626 A MXPA03007626 A MX PA03007626A MX PA03007626 A MXPA03007626 A MX PA03007626A
Authority
MX
Mexico
Prior art keywords
binding protein
heterocarpine
ghrh
human ghrh
human
Prior art date
Application number
MXPA03007626A
Other languages
English (en)
Inventor
Christophe Thurieau
Original Assignee
Conseils De Rech S Et D Aplica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseils De Rech S Et D Aplica filed Critical Conseils De Rech S Et D Aplica
Publication of MXPA03007626A publication Critical patent/MXPA03007626A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MXPA03007626A 2001-02-27 2002-02-26 Heterocarpina, una proteina de union de ghrh humana. MXPA03007626A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0102631A FR2821359B1 (fr) 2001-02-27 2001-02-27 L'heterocarpine, une proteine fixant le ghrh humain
PCT/FR2002/000691 WO2002068461A2 (fr) 2001-02-27 2002-02-26 L'heterocarpine, une proteine fixant le ghrh humain

Publications (1)

Publication Number Publication Date
MXPA03007626A true MXPA03007626A (es) 2003-12-04

Family

ID=8860481

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007626A MXPA03007626A (es) 2001-02-27 2002-02-26 Heterocarpina, una proteina de union de ghrh humana.

Country Status (20)

Country Link
US (1) US7385024B2 (es)
EP (1) EP1409531B1 (es)
JP (1) JP4117194B2 (es)
KR (1) KR20030094262A (es)
CN (1) CN100340573C (es)
AT (1) ATE309269T1 (es)
AU (1) AU2002241065B2 (es)
BR (1) BR0207578A (es)
CA (1) CA2437516A1 (es)
CZ (1) CZ20032612A3 (es)
DE (1) DE60207257T2 (es)
ES (1) ES2252431T3 (es)
FR (1) FR2821359B1 (es)
HU (1) HU225431B1 (es)
IL (2) IL157150A0 (es)
MX (1) MXPA03007626A (es)
NZ (1) NZ527749A (es)
PL (1) PL207581B1 (es)
RU (1) RU2305683C2 (es)
WO (1) WO2002068461A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843697B1 (fr) * 2002-08-26 2005-12-09 Sod Conseils Rech Applic L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
US7494969B2 (en) 2002-02-26 2009-02-24 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Heterocarpine, a plant-derived protein with anti-cancer properties
CN1688696A (zh) * 2002-09-18 2005-10-26 蒙特利尔大学医疗中心 Ghrh类似物
FR2848221B1 (fr) * 2002-12-10 2007-09-28 Sod Conseils Rech Applic Procede de preparation d'heterocarpine recombinante
JP2005289895A (ja) * 2004-03-31 2005-10-20 Kagoshima Tlo Co Ltd 植物タンパク質分離精製法及びそれに用いるタンニン中和剤並びにその調製法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
ES2134280T3 (es) * 1994-03-21 1999-10-01 Nestle Sa Procedimiento de produccion de pilocarpina.
US20050160088A1 (en) 2001-05-17 2005-07-21 Todd Scallan System and method for metadata-based distribution of content

Also Published As

Publication number Publication date
ES2252431T3 (es) 2006-05-16
PL369469A1 (en) 2005-04-18
FR2821359B1 (fr) 2003-05-09
FR2821359A1 (fr) 2002-08-30
CZ20032612A3 (cs) 2004-08-18
CA2437516A1 (fr) 2002-09-06
DE60207257T2 (de) 2006-07-27
IL157150A0 (en) 2004-02-08
RU2003128963A (ru) 2005-02-20
CN100340573C (zh) 2007-10-03
BR0207578A (pt) 2004-03-02
US7385024B2 (en) 2008-06-10
EP1409531A2 (fr) 2004-04-21
DE60207257D1 (de) 2005-12-15
JP4117194B2 (ja) 2008-07-16
NZ527749A (en) 2006-09-29
CN1531550A (zh) 2004-09-22
WO2002068461A2 (fr) 2002-09-06
HUP0303244A2 (hu) 2003-12-29
JP2004538254A (ja) 2004-12-24
ATE309269T1 (de) 2005-11-15
PL207581B1 (pl) 2011-01-31
US20040063621A1 (en) 2004-04-01
RU2305683C2 (ru) 2007-09-10
IL157150A (en) 2008-11-26
EP1409531B1 (fr) 2005-11-09
KR20030094262A (ko) 2003-12-11
AU2002241065B2 (en) 2006-09-28
WO2002068461A3 (fr) 2004-02-12
HU225431B1 (en) 2006-11-28
HUP0303244A3 (en) 2005-11-28

Similar Documents

Publication Publication Date Title
WO2002085299A3 (en) Therapeutic treatments using the direct application of antimicrobial metal compositions
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
EP1390472A4 (en) NUCLEIC ACID TREATMENT OF DISEASES OR SIDES RELATED TO RAS, HER2 AND HIV LEVELS
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
ATE443527T1 (de) 5-cnac zur oralen verabreichung von parathormonfragmenten
WO2003039539A3 (de) Verwendung von endothelin-rezeptor-antagonisten zur behandlung von tumorerkrankungen
WO2003051926A3 (en) Anti-cd7 immunotoxin as fusion protein
IL157150A0 (en) Heterocarpine, a human ghrh-binding protein
TNSN04235A1 (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
WO2002051379A3 (en) Thixotropic nasal spray
WO2004017987A3 (fr) L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
HUP0401589A3 (en) New peptides - analogs of human growth hormone-releasing hormone
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
WO2005120540A3 (en) Interferon alpha or beta for treatment of cardiomyopathy and endothelial dysfunction
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
WO2002100317A3 (en) Targeted particles and methods of using the same
WO2003040119A8 (fr) Inhibiteurs de l'angiogenese
UA34265A (uk) Паста для лікування захворювань тканин пародонту
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
UA83988C2 (ru) Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапии
GB0109383D0 (en) Pharmaceutical formulations, delivery devices for use therewith and methods of treatment
EP1408043A8 (en) 2''oxo-voruscharin and analogues thereof
LT2002105A (en) Novel use of siberian fir oil
WO2002102849A3 (en) Bcmp-101, a cancer associated protein

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status